In May 2024, GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and ...
The global over-the-counter (OTC) veterinary drugs market is on the brink of substantial expansion, forecasting a Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2033. According to the latest ...
We are now in the era of weight-loss drugs. Decisions on how these drugs will be used look likely to shape our future health and even what our society might look like. And, as researchers are ...
Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to 50% according to a new study, adding to mounting evidence that the drugs yield health benefits beyond ...
One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these ...
Journalist Rory Carson spends time in a Larne crack house before examining how one person’s drug use can impact the entire family. Show more Journalist Rory Carson explores the hidden lives of ...
This one-year full-time or two-year part-time master's programme gives you an understanding of applied clinical sciences, research methods and the concepts of oral and maxillofacial surgery. You will ...
Oct 9 (Reuters) - The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be available for no more than $2 for a month's supply ...